Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Analysis of Pathological Stage I Lung Adenocarcinoma Harboring Major EGFR Mutations.
Takamori S, Endo M, Hamada A, Ohara S, Fukuda S, Tomioka Y, Takamori S, Osoegawa A, Nomura K, Fujino K, Yoshikawa M, Suzawa K, Shien K, Suda K, Kinoshita F, Hayasaka K, Notsuda H, Nagano T, Matsudo K, Hashinokuchi A, Matsubara T, Katsumata S, Shiono S, Soh J, Ohde Y, Shimokawa M. Takamori S, et al. Among authors: shimokawa m. Clin Lung Cancer. 2024 Dec 26:S1525-7304(24)00284-5. doi: 10.1016/j.cllc.2024.12.011. Online ahead of print. Clin Lung Cancer. 2024. PMID: 39824660
Sentinel Lymph Node Detection Using SPECT and Gamma Probe in Low-Risk Endometrial Cancer: Efficacy and Factors Associated With Detection Failure.
Asanoma K, Yahata H, Kodama K, Okugawa K, Yasunaga M, Onoyama I, Yagi H, Maenohara S, Hachisuga K, Isoda T, Shimokawa M, Ishigami K, Oda Y, Kato K. Asanoma K, et al. Among authors: shimokawa m. Asian J Endosc Surg. 2025 Jan-Dec;18(1):e70015. doi: 10.1111/ases.70015. Asian J Endosc Surg. 2025. PMID: 39757529 Free PMC article.
A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients With Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring MET Exon 14 Alterations who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial).
Takeda M, Ota M, Iwama E, Sugawara S, Shukuya T, Umemura S, Tanaka H, Oki M, Takahama T, Masuda T, Nogami N, Shimokawa M. Takeda M, et al. Among authors: shimokawa m. Clin Lung Cancer. 2024 Dec 9:S1525-7304(24)00267-5. doi: 10.1016/j.cllc.2024.12.004. Online ahead of print. Clin Lung Cancer. 2024. PMID: 39743377
Immune Stress-induced Tumor Mutation Burden and Neoantigen Expression in 4T1 Mammary Cancer Cells: A Potential Mechanism for Long-term Survival in Patients Treated With Immune Checkpoint Inhibitors.
Ishiguro T, Takeda K, Takayanagi D, Mura E, Suzuki R, Tsurui T, Iriguchi N, Hirasawa Y, Ohkuma R, Shimokawa M, Ariizumi H, Kubota Y, Horiike A, Izumizaki M, Wada S, Yoshimura K, Hoffman RM, Tsunoda T. Ishiguro T, et al. Among authors: shimokawa m. Cancer Genomics Proteomics. 2025 Jan-Feb;22(1):1-12. doi: 10.21873/cgp.20481. Cancer Genomics Proteomics. 2025. PMID: 39730175 Free PMC article.
Impact of the distance of spread through air spaces in non-small cell lung cancer.
Hashinokuchi A, Akamine T, Toyokawa G, Matsudo K, Nagano T, Kinoshita F, Kohno M, Tomonaga T, Kohashi K, Shimokawa M, Oda Y, Takenaka T, Yoshizumi T. Hashinokuchi A, et al. Among authors: shimokawa m. Interdiscip Cardiovasc Thorac Surg. 2024 Dec 25;40(1):ivae181. doi: 10.1093/icvts/ivae181. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 39705189 Free PMC article.
Corrigendum to 'MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC' [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450].
Haratake N, Ozawa H, Morimoto Y, Yamashita N, Daimon T, Bhattacharya A, Wang K, Nakashoji A, Isozaki H, Shimokawa M, Kikutake C, Suyama M, Hashinokuchi A, Takada K, Takenaka T, Yoshizumi T, Mitsudomi T, Hata AN, Kufe D. Haratake N, et al. Among authors: shimokawa m. J Thorac Oncol. 2024 Dec 18:S1556-0864(24)02499-7. doi: 10.1016/j.jtho.2024.12.004. Online ahead of print. J Thorac Oncol. 2024. PMID: 39692639 Free article. No abstract available.
Prognostic impact of PD-L1 expression in surgically resected EGFR-mutant lung adenocarcinoma: A real-world database study in Japan (CReGYT-01 EGFR study).
Nomura K, Takada K, Kinoshita F, Muto S, Matsubara T, Kouki Y, Katsumata S, Hamada A, Haratake N, Fujino K, Yoshikawa M, Suzawa K, Shien K, Suda K, Ohara S, Fukuda S, Suzuki H, Okamoto T, Hirai F, Aokage K, Shiono S, Soh J, Tsuboi M, Shimokawa M, Ohde Y. Nomura K, et al. Among authors: shimokawa m. Int J Cancer. 2024 Nov 21. doi: 10.1002/ijc.35270. Online ahead of print. Int J Cancer. 2024. PMID: 39569608
463 results